Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Finished Goods (2022 - 2024)

Historic Finished Goods for Jin Medical International (ZJYL) over the last 3 years, with Q3 2024 value amounting to $1.4 million.

  • Jin Medical International's Finished Goods rose 6656.59% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 million, marking a year-over-year increase of 6656.59%. This contributed to the annual value of $1.4 million for FY2024, which is 6656.59% up from last year.
  • Jin Medical International's Finished Goods amounted to $1.4 million in Q3 2024, which was up 6656.59% from $820949.0 recorded in Q3 2023.
  • Jin Medical International's 5-year Finished Goods high stood at $2.1 million for Q3 2022, and its period low was $820949.0 during Q3 2023.
  • Its 3-year average for Finished Goods is $1.4 million, with a median of $1.4 million in 2024.
  • In the last 5 years, Jin Medical International's Finished Goods plummeted by 5996.54% in 2023 and then soared by 6656.59% in 2024.
  • Jin Medical International's Finished Goods (Quarter) stood at $2.1 million in 2022, then tumbled by 59.97% to $820949.0 in 2023, then surged by 66.57% to $1.4 million in 2024.
  • Its Finished Goods was $1.4 million in Q3 2024, compared to $820949.0 in Q3 2023 and $2.1 million in Q3 2022.